Azilsartan

DB21772InvestigationalSmall moleculeAngiotensin 2 Receptor Blocker

Azilsartan: Overview.

Mechanism: Pharmacologically active on Type-1 angiotensin II receptor
Curator reviewed
Formula / weight: C₂₅H₂₀N₄O₅ · 456.458 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyKGSXMPPBFPAXLY-UHFFFAOYSA-NSMILESCCOC1=NC2=CC=CC(C(O)=O)=C2N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NC(=O)ON1

Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

25Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Azilsartan, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.